undefined
EUTM file information

018203269

TILMIUS


February 27, 2020

Trademark Summary

The trademark TILMIUS was filed by Fresenius Kabi Deutschland GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on May 27, 2020, and received one opposition filed on August 25, 2020 by Radius Health, Inc. on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by GRÜNECKER and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 25, 2020

The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on November 1, 2020.


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations for human consumption for treatment in the fields of rheumatology, immunology, oncology, oncohaematology, pneumology, infectiology, neurology, dermatology, gastroenterology, ophthalmology and neuromuscular field, all the aforesaid goods other than pharmaceutical preparations for treatment of osteoporosis and for prevention of osteoporotic fractures.